首页> 外文会议>Scale-up and manufacturing of cell-based therapies V >ENGINNERING CARDIAC TISSUE USING HUMAN INDUCED PLURIPOTENT STEM CELL DERIVATIVES: PROTEOMIC CHARACTERIZATION OF CO-CULTURES OF CARDIOMYOCYTES AND ENDOTHELIAL CELLS
【24h】

ENGINNERING CARDIAC TISSUE USING HUMAN INDUCED PLURIPOTENT STEM CELL DERIVATIVES: PROTEOMIC CHARACTERIZATION OF CO-CULTURES OF CARDIOMYOCYTES AND ENDOTHELIAL CELLS

机译:使用人类诱导的多能干细胞衍生物增强心脏组织:心肌细胞和内皮细胞共培养的蛋白质组学表征

获取原文
获取原文并翻译 | 示例

摘要

Prediction of cardiac toxicity effect is extremely relevant in the development of new drugs for different medical applications. In this way, it is important to develop more predictable human cell-based models which physiologically better mimic the human heart and allow the prediction of this toxic effect as well as establish the tools that enable the characterization of these complex cell models. To recreate engineered cardiac tissue, it is essential to reproduce the complexity of the heart by resorting to different cell types. Cardiomyocytes (CMs) are functional contractile units of the heart, and it is known that their communication with endothelial cells (ECs) is crucial for cardiac homeostasis. The aim of this study is to recreate a human pluripotent stem cells (hiPSC)-based cardiac tissue model and evaluate the impact of communication between both cell types on the phenotype of CMs.
机译:在不同医学应用的新药开发中,心脏毒性作用的预测极为重要。以这种方式,重要的是要开发出更多可预测的基于人类细胞的模型,这些模型在生理上更好地模仿人类心脏,并能够预测这种毒性作用,并建立能够表征这些复杂细胞模型的工具。要重建心脏工程组织,必须借助不同的细胞类型来复制心脏的复杂性。心肌细胞(CMs)是心脏的功能性收缩单位,众所周知,它们与内皮细胞(ECs)的通讯对于心脏动态平衡至关重要。这项研究的目的是重建基于人类多能干细胞(hiPSC)的心脏组织模型,并评估两种细胞类型之间的通讯对CMs表型的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号